Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Gilenya prescribing information
A genome screen for multiple sclerosis in Italian families.
Mapi Pharma Receives Additional Claims for Its U.S. Patent for Glatiramer Acetate Depot for the Treatment of Multiple Sclerosis
Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.
Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients.
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials.
Metabolic features of the cell danger response.
FDA warns about seizures linked to MS drug
Laquinimod
Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?
A phase IIa randomised clinical study of GNbAC1, a humanised monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus in multiple sclerosis patients.
Narcolepsy with cataplexy and comorbid immunopathological diseases.
SMC Says Yes to Lemtrada(R)a- 1/4 (alemtuzumab) 12mg IV, a New Treatment for Adults with Active Relapsing Remitting-Multiple Sclerosis (RRMS)
A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica).
Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
Multiple sclerosis and progressive resistance training: a systematic review.
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.
VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells.
A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JC virus testing.
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial.
Inhibition of glycerophosphate-dependent H2O2 generation in brown fat mitochondria by idebenone.

Pages